[Public Notice+] CareLabs "Operating Profit of 3.8 Billion KRW in H1, Up 84% YoY... Surpassing Last Year's Annual Earnings"
[Asia Economy Reporter Hyunseok Yoo] Carelabs announced through its earnings disclosure on the 10th that its consolidated operating profit for the first half of this year reached 3.8 billion KRW, an increase of about 84% compared to the same period last year. This is the highest half-year performance since the company's founding, surpassing last year's full-year operating profit of 3.6 billion KRW by a wide margin. Net profit for the same period also saw a significant increase of about 274%, reaching 2.7 billion KRW. Sales rose by 9% to 37 billion KRW.
On a separate basis, operating profit and net profit for the first half were 4.7 billion KRW and 3.9 billion KRW, respectively, growing by 92% and 207%. Sales increased slightly by about 5% to 29.6 billion KRW.
The company explained that the overall improvement in management structure, centered on ▲ increased demand for non-face-to-face medical services due to COVID-19 ▲ growth of subsidiaries based on newly invested startups ▲ improvement in operating profit margin due to increased sales, has led to a full-fledged profit improvement trend in the first half of this year.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
Park Kyungdeuk, CEO of Carelabs, said, “Since we have continued the record-breaking performance for both the first and second quarters, we plan to focus on solid management to ensure that the growth trend continues in the second half of this year.” He added, “Our subsidiary Goodoc, which currently holds the No. 1 position in the non-face-to-face medical service platform industry, is expected to accelerate its growth and join the ranks of full-scale earnings soon.” He continued, “Meaningful growth momentum such as the overseas expansion of the beauty platform Babitok and the launch of private brand (PB) products will actively drive Carelabs’ growth trend.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.